BioCentury | Apr 15, 2013
Clinical News

Micrologix regulatory update

...been engineered to make, allowing protection for manufacturing almost any biologically active antimicrobial cationic peptide. Micrologix Biotech Inc....
BioCentury | Feb 4, 2008
Clinical News

Celgosivir: Expand Phase II

...in 20 treatment-naïve patients. The expanded trial will enroll up to 50 patients. Migenix (formerly Micrologix Biotech Inc....
BioCentury | Aug 31, 2005
Clinical News

Migenix, Cadence start CPI-226 Phase III

...2003, Fujisawa (Deerfield, Ill.) returned rights to the topical antimicrobial cationic peptide to MGI (formerly Micrologix...
BioCentury | Jun 28, 2005
Clinical News

Cadence gets SPA for CPI-226 Phase III

...TSE:MGI; MGIFF). In 2003, Fujisawa (Deerfield, Ill.) returned rights to the compound to MGI (formerly Micrologix...
BioCentury | Sep 27, 2004
Company News

Migenix sales and marketing update

...The company changed its name to Migenix from Micrologix Biotech Inc. to reflect the new symbol of "MGI"...
BioCentury | Sep 6, 2004
Company News

Micrologix, MitoKor deal

...guidance for a second time to C$11-C$13 million from C$10-C$13 million (see BioCentury, April 19). Micrologix Biotech Inc....
BioCentury | Aug 9, 2004
Company News

Micrologix, Strata Pharmaceuticals Inc. deal

...also will evaluate submitting an NDA based on data from the first Phase III trial. Micrologix Biotech Inc....
BioCentury | Aug 3, 2004
Company News

Micrologix, Strata antibiotic deal

Micrologix (TSE:MBI; MGIXF) granted to Strata (San Diego, Calif.) exclusive European and North American development and marketing rights to MBI-226, a topical antimicrobial cationic peptide to prevent catheter-related infections. Under the deal, MBI will receive...
BioCentury | Jul 26, 2004
Company News

Micrologix other research news

...toxicity was reported at high drug concentrations. Results were reported in Antiviral Chemistry & Chemotherapy. Micrologix Biotech Inc....
BioCentury | Apr 19, 2004
Company News

Micrologix, MitoKor deal

...and Legg Mason Wood Walker advised MitoKor. The deal is expected to close in June. Micrologix Biotech Inc....
Items per page:
1 - 10 of 72
BioCentury | Apr 15, 2013
Clinical News

Micrologix regulatory update

...been engineered to make, allowing protection for manufacturing almost any biologically active antimicrobial cationic peptide. Micrologix Biotech Inc....
BioCentury | Feb 4, 2008
Clinical News

Celgosivir: Expand Phase II

...in 20 treatment-naïve patients. The expanded trial will enroll up to 50 patients. Migenix (formerly Micrologix Biotech Inc....
BioCentury | Aug 31, 2005
Clinical News

Migenix, Cadence start CPI-226 Phase III

...2003, Fujisawa (Deerfield, Ill.) returned rights to the topical antimicrobial cationic peptide to MGI (formerly Micrologix...
BioCentury | Jun 28, 2005
Clinical News

Cadence gets SPA for CPI-226 Phase III

...TSE:MGI; MGIFF). In 2003, Fujisawa (Deerfield, Ill.) returned rights to the compound to MGI (formerly Micrologix...
BioCentury | Sep 27, 2004
Company News

Migenix sales and marketing update

...The company changed its name to Migenix from Micrologix Biotech Inc. to reflect the new symbol of "MGI"...
BioCentury | Sep 6, 2004
Company News

Micrologix, MitoKor deal

...guidance for a second time to C$11-C$13 million from C$10-C$13 million (see BioCentury, April 19). Micrologix Biotech Inc....
BioCentury | Aug 9, 2004
Company News

Micrologix, Strata Pharmaceuticals Inc. deal

...also will evaluate submitting an NDA based on data from the first Phase III trial. Micrologix Biotech Inc....
BioCentury | Aug 3, 2004
Company News

Micrologix, Strata antibiotic deal

Micrologix (TSE:MBI; MGIXF) granted to Strata (San Diego, Calif.) exclusive European and North American development and marketing rights to MBI-226, a topical antimicrobial cationic peptide to prevent catheter-related infections. Under the deal, MBI will receive...
BioCentury | Jul 26, 2004
Company News

Micrologix other research news

...toxicity was reported at high drug concentrations. Results were reported in Antiviral Chemistry & Chemotherapy. Micrologix Biotech Inc....
BioCentury | Apr 19, 2004
Company News

Micrologix, MitoKor deal

...and Legg Mason Wood Walker advised MitoKor. The deal is expected to close in June. Micrologix Biotech Inc....
Items per page:
1 - 10 of 72